0
ALERT Communities Act
3/18/2025, 2:18 PM
Summary of Bill HR 1561
The bill also authorizes the use of grant funds to purchase and distribute these test strips, making them more accessible to communities and individuals at risk of opioid overdose. This provision is crucial in combating the opioid crisis and saving lives.
Overall, the Fentanyl and Xylazine Test Strips Research Act is a proactive measure to address the opioid epidemic by promoting research and increasing access to tools that can help prevent overdoses. It is a bipartisan effort to tackle a pressing public health issue and protect the well-being of individuals across the country.
Congressional Summary of HR 1561
Advancing Lifesaving Efforts with Rapid Test strips for Communities Act or the ALERT Communities Act
This bill establishes programs and requirements to advance the development and usage of test strips that detect the presence of certain hazardous drugs (e.g., fentanyl, xylazine).
Currently, the Substance Abuse and Mental Health Services Administration provides grants to government entities to train and provide authorized equipment to first responders and other relevant personnel for emergency treatment of opioid overdoses. The bill expands these grants to include rapid response test strips for detecting the presence of fentanyl, xylazine, and other synthetic opioids or emerging substances in people or within other drugs.
Additionally, the bill requires the Department of Health and Human Services (HHS) to publish guidance and standards for test strip manufacturers to support the development, evaluation, and authorization of test strips.
Also, HHS must conduct a study and report to Congress on how the availability and usage of test strips and similar equipment impacts the frequency of overdoses and participation in substance use disorder treatment.
